AtriCure, Inc. Files 8-K on Financials

Ticker: ATRC · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1323885

Sentiment: neutral

Topics: financial-disclosure, 8-k, operations

Related Tickers: ATRC

TL;DR

ATRC filed an 8-K on Jan 13, 2025, detailing financial results and disclosures.

AI Summary

AtriCure, Inc. filed an 8-K on January 13, 2025, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits. The filing details the company's financial performance and related disclosures.

Why It Matters

This 8-K filing provides crucial updates on AtriCure's financial condition and operational results, which can impact investor decisions.

Risk Assessment

Risk Level: low — This is a routine financial disclosure filing and does not inherently present new risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by AtriCure, Inc.?

The primary purpose is to report on the company's Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.

On what date was this 8-K report filed?

The report was filed on January 13, 2025.

What is AtriCure, Inc.'s principal executive office address?

The principal executive office is located at 7555 Innovation Way, Mason OH 45040.

Under which sections of the Securities Exchange Act of 1934 is this report filed?

This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is the Standard Industrial Classification code for AtriCure, Inc.?

The Standard Industrial Classification code is 3841, for SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Filing Stats: 855 words · 3 min read · ~3 pages · Grade level 10.2 · Accepted 2025-01-13 08:00:29

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On January 13, 2025, AtriCure issued a press release announcing its preliminary financial results for the fourth quarter and full year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference. The information in Item 2.02 of Form 8-K and in the press release attached as Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in each of Item 2.02 of this Form 8-K and Exhibit 99.1 shall not be incorporated by reference in any filing or other document under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing or document.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. During the week of January 13, 2025 the Company is holding meetings with investors discussing, among other topics, an overview of the Company's business and growth strategy. A copy of the investor presentation, which is available at www.atricure.com, is furnished as Exhibit 99.2 to this Form 8-K and is incorporated herein by reference. Information in the presentation and the press release contains forward-looking statements regarding future events and performance of the Company. All such forward-looking statements are based largely on the Company's experience and perception of current conditions, trends, expected future developments and other factors, and on management's expectations, and are subject to risks and uncertainties that could cause actual results to differ materially, including, but not limited to, those factors described in the presentation and in the Company's filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any financial or other projections or other forward-looking statements, whether because of new information, future events or otherwise. The information in each of Item 2.02 and Item 7.01 of this Form 8-K and in the press release attached as Exhibit 99.1 and the presentation attached as Exhibit 99.2 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in each of Item 2.02 and Item 7.01 of this Form 8-K and each of Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference in any filing (whether made before or after the date hereof) or any other document under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such filing or document.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 99.1 Press Release dated January 13, 2025. 99.2 Investor Presentation. 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATRICURE, INC. Dated: January 13, 2025 By: /s/ Angela L. Wirick Angela L. Wirick Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing